<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03642639</url>
  </required_header>
  <id_info>
    <org_study_id>CNV_2017_01</org_study_id>
    <nct_id>NCT03642639</nct_id>
  </id_info>
  <brief_title>A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial Aneurysms</brief_title>
  <acronym>STERLING</acronym>
  <official_title>A Prospective, Multi-center, Single Arm Study to Obtain &quot;Real World&quot; Clinical Data and Characterize the Acute and Long-term Performance of the MICRUSFRAME and GALAXY Coils Including the PulseRider Aneurysm Neck Reconstruction Device for the Endovascular Treatment of Intracranial Aneurysms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cerenovus, Part of DePuy Synthes Products, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cerenovus, Part of DePuy Synthes Products, Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A post-market registry evaluating ruptured/unruptured aneurysms treated with MICRUSFRAME and
      GALAXY coils
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A registry to collect real world data on the use of Cerenovus coils. The study will be a
      post-market registry evaluating ruptured/unruptured aneurysms treated with MICRUSFRAME and
      GALAXY coils
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 23, 2018</start_date>
  <completion_date type="Anticipated">January 28, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 29, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occlusion Rate</measure>
    <time_frame>12 Months</time_frame>
    <description>Occlusion rate at 12 Months post procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>1. Packing Density</measure>
    <time_frame>From enrollment to end of treatment at 12 months</time_frame>
    <description>Packing density will be evaluated based on aneurysm volume and the coils used during the procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2. Complete occlusion rate</measure>
    <time_frame>12 month</time_frame>
    <description>Complete occlusion rate at 12 month follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>3. Recanalization Rate</measure>
    <time_frame>12 Months</time_frame>
    <description>Recanalization Rate: Any worsening of occlusion grading at 12 Month follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>4. Device related serious adverse events</measure>
    <time_frame>12 Months</time_frame>
    <description>Any device related serious adverse events will be reported through 12 month follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>5. Retreatment Rate</measure>
    <time_frame>12 Months</time_frame>
    <description>Aneurysm re-treatment rates will be tracked and recorded during the 12 month follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6. Modified Rankin Score</measure>
    <time_frame>12 Months</time_frame>
    <description>Modified Rankin Score (Scale from 0-6) at 12 Months. 0 - No symptoms.
- No significant disability. Able to carry out all usual activities, despite some symptoms.
- Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities.
- Moderate disability. Requires some help, but able to walk unassisted.
- Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted.
- Severe disability. Requires constant nursing care and attention, bedridden, incontinent.
- Dead.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>7. Length of hospital stay</measure>
    <time_frame>From enrollment to 12 Months</time_frame>
    <description>Hospital stay length will be recorded</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">850</enrollment>
  <condition>Aneurysms</condition>
  <arm_group>
    <arm_group_label>Coils</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>MICRUSFRAME and GALAXY coils</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MICRUSFRAME and GALAXY coils</intervention_name>
    <description>MICRUSFRAME and GALAXY Coils</description>
    <arm_group_label>Coils</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient is between 21 and 80 years of age

          2. Patient has an intracranial saccular aneurysm, ruptured or unruptured, suitable for
             embolization with coils

          3. Patient is able and willing to comply with protocol and follow-up requirements

        Exclusion Criteria:

          1. Pre-planned staged procedure on unruptured aneurysm

          2. More than one aneurysm requiring treatment during the course of study

          3. Fusiform aneurysm
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Reade De Leacy</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mount Sinai Hospital, New York</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Osama Zaidat</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mercy Health St. Vincent Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lillian Ma</last_name>
    <phone>9494668021</phone>
    <email>lma46@its.jnj.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mount Sinai Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Reade De Leacy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mercy Health St. Vincent Medical Center</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43604</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Osama Zaidat, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>July 11, 2018</study_first_submitted>
  <study_first_submitted_qc>August 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 22, 2018</study_first_posted>
  <last_update_submitted>April 20, 2020</last_update_submitted>
  <last_update_submitted_qc>April 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intracranial Aneurysm</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

